[ad_1]
NEW DELHI: The Indian Council for Medical Research, India's largest health research organization, will begin testing the locally developed vaccine against the Zika virus, cases of which have been reported in Madhya Pradesh, Rajasthan and Gujarat.
ICMR will undertake a Phase II trial of the vaccine to determine its efficacy and safety, as well as any adverse effects, said an agency official reporting to the Ministry of the Union for Health and Safety. protection of the family.
Bharat Biotech, based in Hyderabad, has developed the vaccine that they say will provide protection against infections caused by Asian and African strains of Zika virus, said the official.
"The company had developed the vaccine about two years ago. At that time, the Zika epidemic only concerned Latin America and no cases were reported in India, "said the official.
"The Zika virus affects people primarily by the bite of a mosquito of the infected Aedes species. An epidemic has been reported in some states. Vector control is hard work. Therefore, treatment with a vaccine is the best way to deal with this epidemic, "said the official.
The regulatory approval process to complete the test will be launched soon.
Source link